Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-05 Sale | 2024-03-07 4:59 pm | Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CHIEF COMMERCIAL OFFICER | 1,682 | $16.55 | $27,837 | 33,918 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-18 Option Award | 2024-01-22 6:00 pm | N/A 2034-01-18 | Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CHIEF COMMERCIAL OFFICER | 53,500 | $0 | 71,300 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 4:32 pm | N/A 2033-01-26 | Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CHIEF COMMERCIAL OFFICER | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 4:40 pm | N/A 2033-01-17 | Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CHIEF COMMERCIAL OFFICER | 53,500 | $0 | 53,500 (Direct) | View |
| 2022-04-26 Option Award | 2022-04-28 6:20 pm | N/A 2032-04-26 | Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CCO | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-12-14 Option Award | 2021-12-23 4:55 pm | N/A 2031-12-14 | Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CCO | 64,000 | $0 | 64,000 (Direct) | View |